NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 8 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,676 | -13.4% | 11,192 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,250 | +41.0% | 11,192 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $13,654 | -54.5% | 11,192 | -32.3% | 0.00% | 0.0% |
| Q3 2022 | $30,000 | -77.6% | 16,532 | -58.3% | 0.00% | -83.3% |
| Q2 2022 | $134,000 | – | 39,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vanguard Personalized Indexing Management, LLC | 39,634 | $134,000 | 0.01% |
| CLEAR STREET LLC | 7,157 | $24,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 9,794 | $33,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,259 | $68,000 | 0.00% |
| CITIGROUP INC | 49,744 | $168,000 | 0.00% |
| JANE STREET GROUP, LLC | 77,249 | $261,000 | 0.00% |
| UBS Group AG | 13,428 | $45,000 | 0.00% |